IL17A and psoriasis: Because the patient did not have a history of gastrointestinal symptoms and the only significant aspect in the personal history was a long-standing psoriasis with psoriatic arthritis under with secukinumab, the final diagnosis was asymptomatic CD, probably in the context of biologic therapy with an IL-17 inhibitor [61].